Serigen receives the DBT-BIRAC-SBIRI grant funding

Serigen (previously BiolMed) has been awarded an Small Business Innovation Research Initiative (SBIRI) grant by Biotechnology Industry Research Assistance Council (BIRAC). BIRAC is an innovation agency setup by Government of India. The funding will accelerate product development of Serimat. The project would enable Serigen to complete advance prototyping and preclinical studies for Serimat. Serimat is a soft tissue regeneration matrix.  Further, it will enable Serigen to establish biocompatibility and efficacy of Serimat in breast reconstruction surgeries.